Aura Biosciences, Inc. (NASDAQ:AURA) People

Aura Biosciences, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Natalie Holles
Other companies: LeonaBio, Inc. (Board Member | Chief Executive Officer · Since at least May 5, 2026); Third Harmonic Bio Inc. (CEO, Director · Since at least Sep 14, 2022); Day One Biopharmaceuticals Inc (Director · Since at least May 26, 2021); Allakos Inc (Director · Dec 21, 2020 – May 25, 2021 · Past); Rubius Therapeutics Inc (Director · Mar 19, 2019 – May 12, 2022 · Past); Audentes Therapeutics Inc (President and COO · Jul 19, 2016 – Jan 15, 2020 · Past); Hyperion Therapeutics Inc (SVP, Business Development · Jun 24, 2013 – May 7, 2015 · Past)
Chief Executive Officer and President and member of the Board · Since at least Apr 30, 2026
Jeremy Bender
Other companies: Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Mereo BioPharma Group plc (Non-Executive Director · Since at least Jan 1, 2024); Day One Biopharmaceuticals Inc (CHIEF EXECUTIVE OFFICER, Director · Since at least May 26, 2021); Fusion Pharmaceuticals Inc (Director · Oct 16, 2023 – Jun 4, 2024 · Past)
Director · Since at least Jul 7, 2026
Sapna Srivastava
Other companies: Alumis Inc. (Director · Since at least Jul 30, 2025); Nuvalent, Inc. (Director · Since at least Jun 18, 2025); Tourmaline Bio Inc. (Director · Since at least Jun 4, 2025)
Director · Since at least Jun 17, 2025
David Johnson
Other companies: Zentalis Pharmaceuticals, Inc. (Director · Since at least Apr 3, 2020); Dynavax Technologies Corporation (Vice President · Jun 2, 2019 – Mar 13, 2020 · Past)
Chairman · Since at least Oct 28, 2021
Julie B Feder
Other companies: Obsidian Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 3, 2026); Verastem, Inc. (Chief Financial Officer · Jul 10, 2017 – Apr 6, 2018 · Past)
Chief Financial Officer · Oct 28, 2021 – Oct 18, 2024 · Past
Teresa Bitetti
Other companies: Takeda Pharmaceutical Co. Ltd. (President, Global Oncology Business Unit · Since at least Jan 5, 2026); Fusion Pharmaceuticals Inc (Director · Oct 16, 2023 – Jun 4, 2024 · Past)
Director · Since at least Mar 31, 2025
Anthony S Gibney
Other companies: InflaRx N.V. (Director · Since at least Mar 18, 2026)
See Remarks · Since at least May 13, 2025
Antony Mattessich
Other companies: Ocular Therapeutix, Inc. (President and CEO, Director · Jun 20, 2017 – Feb 3, 2024 · Past)
Director · Since at least Oct 28, 2021
Mark Plavsic
Other companies: Fate Therapeutics, Inc. (Chief Technical Officer · Jun 14, 2021 – Jan 10, 2023 · Past)
Chief Technology Officer · Since at least Mar 15, 2024
Rajesh R Parekh
Other companies: Celldex Therapeutics, Inc. (Director · Dec 23, 2009 – Sep 22, 2010 · Past)
Director · Oct 28, 2021 – Jun 7, 2023 · Past
Amy ElazzouziPrincipal Accounting Officer, Senior Vice President of Finance and Treasurer · Since at least Oct 25, 2024
Anthony DanielsVice President, Therapeutic Area Head Ocular Oncology · Since at least Nov 5, 2026
Conor KilroySee Remarks · Since at least Apr 16, 2026
Erica KratzChief Regulatory and Quality Officer · Since at least Aug 11, 2026
Giovanni MariggiDirector · Since at least Oct 28, 2021
Janet Jill HopkinsChief Medical Officer · Since at least Sep 1, 2026
Jill HopkinsChief Medical Officer, President of Research & Development · Since at least Jun 1, 2026
Julie PersonChief People Officer · Since at least Aug 11, 2026
Patrick NealonSenior Vice President, Clinical Development Operations · Since at least Nov 5, 2026
Pinos Elisabet de losSee Remarks, Director · Since at least Oct 28, 2021
Susan Abu-AbsiChief Operating Officer · Since at least Aug 10, 2026